Hankintapäätös
The Novo Nordisk Foundation Center for Basic Metabolic Research intends to acquire a sequencer to be used for research within metabolism. The sequencer is required to be flexible with a scalable output from low output — 70 GB for new test protocols to high output — 6 000 GB for implemented protocols.